Sun Pharmaceutical Industries Inc recalls Liothyronine Sodium Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications
- Products
-
- Liothyronine Sodium Tablets
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 96,192 bottles
- About this recall
- Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. NDC 62756-589-88